TMC435 in combination with peginterferon and ribavirin for treatment of HCV genotype 1 infection: Week 24 interim analyses of Phase IIB PILLAR and ASPIRE trials
Reported by Jules Levin
ICAAC 2011 Chicago September
Michael W Fried,1 Stefan Zeuzem,2 Goedele De Smedt,3 Maria Beumont-Mauviel3
